|
AngioDynamics, Inc. (AngioDynamics), a public medical device company, is engaged in designing, developing, manufacturing and marketing therapeutic and diagnostic devices for the treatment of peripheral vascular disease (PVD) and other non-coronary diseases. It focuses on the development of innovative, minimally invasive, image-guided procedures to treat PVD and oncology therapy options including radiofrequency ablation, systems, irreversible electroporation, surgical resection systems and embolization products for the treatment of cancer. The company offers its products to interventional physicians, interventional radiologists, vascular surgeons and others. It holds three wholly owned subsidiaries and its products are sold through direct sales force in the US and through a network of distributors outside the US markets. The company operates principally in the US and Europe. It is headquartered in New York, the US. ( http://www.companyprofilesandconferences.com/report/AngioDynamics-Inc-ANGO-Product-Pipeline-Analysis.html ) This report is a source for data, analysis and actionable intelligence on the AngioDynamics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. For more information kindly visit : http://www.companyprofilesandconferences.com/report/AngioDynamics-Inc-ANGO-Product-Pipeline-Analysis.html Or Contact us at : Company Profiles and Conferences Flat A-1901/02, 19th floor, Kshitij Building,Sec-19, Palm Beach Road, Sanpada, Navi Mumbai - 400705, India. Phone : +91 22 2756 1536 Fax : +91 22 2757 9131 E-mail : info@companyprofilesandconferences.com Website : www.companyprofilesandconferences.com
Related Articles -
Company Pofiles, Angio Dynamics Inc, ANGO, Company Profile,
|
